Biocon Warns: US Tariffs on Pharma Imports Could Squeeze Profit Margins and Disrupt Medicine Supply
Biocon cautions that proposed US tariffs on pharmaceutical imports could affect profit margins and the availability of affordable generic medicines, with the company exploring grow...
